In this issue:
Guideline for the management of hypertrophic cardiomyopathy
Performance and quality measures for valvular and structural heart disease
Expert Consensus Statement on cardiac amyloidosis
Effect of SGLT2 inhibitors on heart failure outcomes
Semaglutide reduces the need for loop diuretics in heart failure
Vaccination against COVID-19 and clinical outcomes in heart failure
SEQUOIA-HCM trial in obstructive hypertrophic cardiomyopathy
Nurse Practitioner prescribing for empagliflozin amended
Lokelma approved for hyperkalaemia
Artificial intelligence and its role in diagnosing heart failure
Yoga linked to improved heart failure symptoms
Robot-assisted PCI
Please login below to download this issue (PDF)